-
1دورية أكاديمية
المؤلفون: Wu L; Department of Global Health, University of Washington, 908 Jefferson Street, Seattle, WA, 98104, USA.; Department of Epidemiology, University of Washington, 3980 15th Ave NE, Seattle, WA, 98195, USA., Niu X; Department of Global Health, University of Washington, 908 Jefferson Street, Seattle, WA, 98104, USA.; Department of Epidemiology, University of Washington, 3980 15th Ave NE, Seattle, WA, 98195, USA., Brunelli MK; School of Public Health, University of Washington, Seattle, WA, USA., Mugwanya KK; Department of Global Health, University of Washington, 908 Jefferson Street, Seattle, WA, 98104, USA. mugwanya@uw.edu.; Department of Epidemiology, University of Washington, 3980 15th Ave NE, Seattle, WA, 98195, USA. mugwanya@uw.edu.
المصدر: Current HIV/AIDS reports [Curr HIV/AIDS Rep] 2024 Oct; Vol. 21 (5), pp. 264-281. Date of Electronic Publication: 2024 Aug 09.
نوع المنشور: Systematic Review; Journal Article; Review
بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 101235661 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1548-3576 (Electronic) Linking ISSN: 15483568 NLM ISO Abbreviation: Curr HIV/AIDS Rep Subsets: MEDLINE
مواضيع طبية MeSH: Pre-Exposure Prophylaxis*/methods , HIV Infections*/prevention & control , HIV Infections*/drug therapy , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/administration & dosage , Medication Adherence*/statistics & numerical data , Tenofovir*/therapeutic use , Tenofovir*/administration & dosage, Humans ; Female ; Emtricitabine/therapeutic use ; Emtricitabine/administration & dosage ; Pregnancy ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage ; Leukocytes, Mononuclear ; Adenine/analogs & derivatives ; Organophosphates
-
2دورية أكاديمية
المؤلفون: Patel N; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA., Morris S; School of Medicine, University of California San Diego, La Jolla, California, USA.; AntiViral Research Center, University of California San Diego, La Jolla, California, USA., Burke L; AntiViral Research Center, University of California San Diego, La Jolla, California, USA., Chow K; AntiViral Research Center, University of California San Diego, La Jolla, California, USA., Pacheco D; AntiViral Research Center, University of California San Diego, La Jolla, California, USA., Anderson P; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Stancyzk F; University of Southern California, Los Angeles, California, USA., Blumenthal J; School of Medicine, University of California San Diego, La Jolla, California, USA.; AntiViral Research Center, University of California San Diego, La Jolla, California, USA.
المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Oct; Vol. 90 (10), pp. 2360-2365. Date of Electronic Publication: 2024 Apr 22.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Transgender Persons* , Tenofovir*/administration & dosage , Tenofovir*/analogs & derivatives , HIV Infections*/prevention & control , Pre-Exposure Prophylaxis*/methods , Anti-HIV Agents*/administration & dosage , Anti-HIV Agents*/pharmacokinetics , Adenine*/analogs & derivatives , Adenine*/administration & dosage , Adenine*/therapeutic use , Adenine*/pharmacokinetics , Adenine*/blood, Humans ; Male ; Adult ; Female ; Middle Aged ; Emtricitabine/administration & dosage ; Alanine/administration & dosage ; Alanine/blood ; Drug Substitution ; Drug Combinations ; Young Adult ; Organophosphates/administration & dosage ; Organophosphates/blood ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage ; Phosphorous Acids/administration & dosage
-
3دورية أكاديمية
المؤلفون: Rodriguez CA; Department of Pediatrics, Division of Infectious Diseases, Morsani College of Medicine, University of South Florida, Tampa, FL, USA., Natukunda E; Joint Clinical Research Centre, Kampala, Uganda., Strehlau R; VIDA-Nkanyezi Research Unit, Department of Paediatrics and Child Health, University of the Witwatersrand, Johannesburg, South Africa., Venter EL; The Aurum Institute, Pretoria, South Africa., Rungmaitree S; Department of Paediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Cunningham CK; School of Medicine, University of California Irvine (UCI), Irvine, CA, USA; Children's Hospital of Orange County, Orange, CA, USA., Lalloo U; Durban International Clinical Research Site, Durban University of Technology, Durban, South Africa., Kosalaraksa P; Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., HellstrÖm E; Be Part Yoluntu Centre, Paarl, South Africa., Liberty A; Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, Soweto, South Africa., McGrath EJ; Division of Infectious Diseases & Prevention, Wayne State University School of Medicine, Detroit, MI, USA., Kaur M; Gilead Sciences, Foster City, CA, USA., Leisegang R; Gilead Sciences, Foster City, CA, USA., Hindman JT; Gilead Sciences, Foster City, CA, USA., Vieira VA; Gilead Sciences, Foster City, CA, USA., Kersey K; Gilead Sciences, Foster City, CA, USA., Cotton MF; Department of Paediatrics and Child Health, Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa., Rakhmanina N; Division of Infectious Diseases, Children's National Hospital, Washington, DC, USA; School of Medicine and Health Sciences, The George Washington University, Washington, DC, USA; Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA., Gaur AH; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: aditya.gaur@stjude.org.
المصدر: The lancet. HIV [Lancet HIV] 2024 May; Vol. 11 (5), pp. e300-e308. Date of Electronic Publication: 2024 Apr 12.
نوع المنشور: Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase III; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE
مواضيع طبية MeSH: Tenofovir*/*analogs & derivatives, Emtricitabine*/pharmacokinetics , Emtricitabine*/administration & dosage , Emtricitabine*/therapeutic use , Emtricitabine*/adverse effects , HIV Infections*/drug therapy , HIV Infections*/virology , Tenofovir*/pharmacokinetics , Tenofovir*/administration & dosage , Tenofovir*/adverse effects , Tenofovir*/therapeutic use , Anti-HIV Agents*/pharmacokinetics , Anti-HIV Agents*/adverse effects , Anti-HIV Agents*/administration & dosage , Anti-HIV Agents*/therapeutic use , Alanine*/pharmacokinetics , Alanine*/adverse effects , Heterocyclic Compounds, 4 or More Rings*/pharmacokinetics , Heterocyclic Compounds, 4 or More Rings*/adverse effects , Heterocyclic Compounds, 4 or More Rings*/administration & dosage , Amides*/pharmacokinetics , Pyridones*/pharmacokinetics , Pyridones*/adverse effects , Heterocyclic Compounds, 3-Ring*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/adverse effects , Heterocyclic Compounds, 3-Ring*/administration & dosage , Piperazines*/adverse effects , Piperazines*/pharmacokinetics , Adenine*/analogs & derivatives , Adenine*/pharmacokinetics , Adenine*/adverse effects , Adenine*/administration & dosage , Adenine*/therapeutic use, Humans ; Child ; Male ; Female ; Child, Preschool ; Adolescent ; Thailand ; United States ; South Africa ; Drug Combinations ; Uganda ; Viral Load/drug effects
-
4دورية أكاديمية
المؤلفون: Byonanebye DM; Kirby Institute, University of New South Wales, Kensington, NSW, Australia; School of Public Health, Makerere University, Kampala, Uganda. Electronic address: dbyonanebye@musph.ac.ug., Polizzotto MN; The Australian National University, Canberra, ACT, Australia., Maltez F; Hospital Curry Cabral, Lisbon, Portugal., Rauch A; Department of Infectious Diseases, Inselspital, Bern University Hospital, Bern, Switzerland., Grabmeier-Pfistershammer K; Medizinische Universität Wien, Vienna, Austria., Wit F; Stichting HIV Monitoring, Amsterdam, Netherlands., De Wit S; Department of Infectious Diseases, St Pierre University Hospital Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy., d'Arminio Monforte A; ASST Santi Paolo e Carlo, Milan, Italy., Mussini C; Università degli Studi di Modena, Modena, Italy., Wasmuth JC; University Hospital Bonn, Bonn, Germany., Fontas E; Nice HIV cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Abela I; University of Zurich, Zurich, Switzerland; University Hospital of Zurich, Zurich, Switzerland., Sarcletti M; Department of Dermatology, Venerology, and Allergology, Medical University Innsbruck, Innsbruck, Austria., Bansi-Matharu L; Center for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Jaschinski N; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Peters L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hosein SR; European AIDS Treatment Group, Brussels, Belgium., Vannappagari V; ViiV Healthcare, Durham, NC, USA., Cohen C; Gilead Sciences, Foster City, CA, USA., Bissio E; Merck Sharp & Dohme, Madrid, Spain., Mocroft A; Center for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Law M; Kirby Institute, University of New South Wales, Kensington, NSW, Australia., Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Petoumenos K; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
مؤلفون مشاركون: RESPOND study group
المصدر: The lancet. HIV [Lancet HIV] 2024 May; Vol. 11 (5), pp. e321-e332. Date of Electronic Publication: 2024 Apr 12.
نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE
مواضيع طبية MeSH: Tenofovir*/*analogs & derivatives, HIV Infections*/drug therapy , Tenofovir*/adverse effects , Tenofovir*/therapeutic use , Hypertension*/epidemiology , Hypertension*/chemically induced , Dyslipidemias*/chemically induced , Dyslipidemias*/epidemiology , Body Mass Index*, Humans ; Female ; Male ; Prospective Studies ; Middle Aged ; Adult ; HIV Integrase Inhibitors/adverse effects ; HIV Integrase Inhibitors/therapeutic use ; Alanine/adverse effects ; Australia/epidemiology ; Anti-HIV Agents/adverse effects ; Anti-HIV Agents/therapeutic use ; Weight Gain/drug effects ; Europe/epidemiology ; Risk Factors ; Drug Therapy, Combination/adverse effects
-
5دورية أكاديمية
المؤلفون: Costa-Tuna A; CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal., Chaves OA; CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal.; Laboratory of Immunopharmacology, Centro de Pesquisa, Inovação e Vigilância em COVID-19 e Emergências Sanitárias (CPIV), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21040-361, RJ, Brazil., Almeida ZL; CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal., Cunha RS; CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal., Pina J; CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal., Serpa C; CQC-IMS, Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal.
المصدر: Viruses [Viruses] 2024 Mar 22; Vol. 16 (4). Date of Electronic Publication: 2024 Mar 22.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
مواضيع طبية MeSH: Tenofovir*/*analogs & derivatives, Reverse Transcriptase Inhibitors*/metabolism , Reverse Transcriptase Inhibitors*/chemistry , Tenofovir*/metabolism , Tenofovir*/chemistry , Serum Albumin, Human*/metabolism , Serum Albumin, Human*/chemistry , Protein Binding* , Anti-HIV Agents*/metabolism, Humans ; Thermodynamics ; Calorimetry ; Binding Sites ; HIV Infections/virology ; HIV Infections/drug therapy ; Alanine/metabolism ; HIV Reverse Transcriptase/metabolism ; HIV Reverse Transcriptase/chemistry
-
6دورية أكاديمية
المؤلفون: Yoo JJ; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea., Jung EA; Department of Medical Library, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea., Kim SG; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea., Kim YS; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea., Kim MJ; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
المصدر: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Sep; Vol. 27 (9), pp. e26358.
نوع المنشور: Journal Article; Systematic Review; Meta-Analysis
بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: Switzerland NLM ID: 101478566 Publication Model: Print Cited Medium: Internet ISSN: 1758-2652 (Electronic) Linking ISSN: 17582652 NLM ISO Abbreviation: J Int AIDS Soc Subsets: MEDLINE
مواضيع طبية MeSH: HIV Infections*/drug therapy , Tenofovir*/therapeutic use , Tenofovir*/adverse effects , Tenofovir*/analogs & derivatives , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/adverse effects , Dyslipidemias*/chemically induced, Humans ; Alanine/therapeutic use ; Risk Factors ; Male ; Aminobutyrates/adverse effects ; Aminobutyrates/therapeutic use ; Female ; Adenine/analogs & derivatives ; Adenine/therapeutic use ; Adenine/adverse effects
-
7دورية أكاديمية
المؤلفون: Nam H; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Republic of Korea., Han JW; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee SK; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea., Yang H; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee HL; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Republic of Korea., Sung PS; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Song MJ; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Republic of Korea., Kwon JH; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea., Jang JW; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Chang UI; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Republic of Korea., Kim CW; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Republic of Korea., Nam SW; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea., Bae SH; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Choi JY; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yoon SK; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yang JM; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Republic of Korea., Kim HY; The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hepatology, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon-si, Republic of Korea.
المصدر: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2024 Aug; Vol. 39 (8), pp. 1673-1683. Date of Electronic Publication: 2024 May 01.
نوع المنشور: Journal Article; Multicenter Study
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: Australia NLM ID: 8607909 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1440-1746 (Electronic) Linking ISSN: 08159319 NLM ISO Abbreviation: J Gastroenterol Hepatol Subsets: MEDLINE
مواضيع طبية MeSH: Tenofovir*/therapeutic use , Tenofovir*/administration & dosage , Tenofovir*/adverse effects , Tenofovir*/analogs & derivatives , Hepatitis B, Chronic*/drug therapy , Glomerular Filtration Rate*/drug effects , Drug Substitution* , Bone Density*/drug effects , Alanine*/therapeutic use , Antiviral Agents*/administration & dosage , Antiviral Agents*/adverse effects, Humans ; Male ; Middle Aged ; Female ; Retrospective Studies ; Treatment Outcome ; Adenine/analogs & derivatives ; Adenine/therapeutic use ; Adenine/adverse effects ; Adenine/administration & dosage ; Aged ; Adult
-
8دورية أكاديمية
المؤلفون: Riddler SA; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Kelly CW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hoesley CJ; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Department of Medical Education, University of Alabama at Birmingham, Birmingham, Alabama, USA., Ho KS; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Piper JM; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA., Edick S; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Heard F; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Doncel GF; CONRAD, Eastern Virginia Medical School, Norfolk, Virginia, USA., Johnson S; FHI 360, Durham, North Carolina, USA., Anderson PL; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Brand RM; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA., Kunjara Na Ayudhya RP; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA., Bauermeister JA; Department of Family and Community Health, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania, USA., Hillier SL; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.; Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Hendrix CW; Department of Medicine, Clinical Pharmacology, Johns Hopkins University, Baltimore, Maryland, USA.
المصدر: The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. 696-705.
نوع المنشور: Journal Article; Clinical Trial, Phase I
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Tenofovir*/pharmacokinetics , Tenofovir*/administration & dosage , Tenofovir*/analogs & derivatives , HIV Infections*/prevention & control , HIV Infections*/drug therapy , Quinolones*/pharmacokinetics , Quinolones*/administration & dosage , Quinolones*/adverse effects , Anti-HIV Agents*/pharmacokinetics , Anti-HIV Agents*/administration & dosage , Anti-HIV Agents*/adverse effects , Alanine*/pharmacokinetics , Alanine*/administration & dosage , Adenine*/analogs & derivatives , Adenine*/pharmacokinetics , Adenine*/administration & dosage , Adenine*/adverse effects , Administration, Rectal*, Humans ; Male ; Adult ; Female ; Middle Aged ; Rectum/virology ; Young Adult ; HIV-1/drug effects ; Drug Combinations
-
9دورية أكاديمية
المؤلفون: Long J; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China., Saw M; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. max_saw@yahoo.com., Zhang P; Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China. zhangwangpan71@163.com., Wang L; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China., Li L; Department of Pharmacy, Jing'an District Central Hospital, Fudan University, Shanghai, China., Ren H; Shanghai Mobio Biomedical Technology Co., Shanghai, China., Liu C; Shanghai Mobio Biomedical Technology Co., Shanghai, China., Ma Z; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China., Zhang J; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China. jmzhang@fudan.edu.cn.; Department of Infectious Diseases, Jing'An Branch of Huashan Hospital, Fudan University, Shanghai, China. jmzhang@fudan.edu.cn., Wang B; Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai, China. wangbin@huashan.org.cn.; Department of Pharmacy, Jing'an District Central Hospital, Fudan University, Shanghai, China. wangbin@huashan.org.cn.
المصدر: BMC microbiology [BMC Microbiol] 2024 Sep 20; Vol. 24 (1), pp. 359. Date of Electronic Publication: 2024 Sep 20.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180 (Electronic) Linking ISSN: 14712180 NLM ISO Abbreviation: BMC Microbiol Subsets: MEDLINE
مواضيع طبية MeSH: Dysbiosis*/microbiology , Gastrointestinal Microbiome*/drug effects , Tenofovir*/therapeutic use , Tenofovir*/administration & dosage , Hepatitis B, Chronic*/drug therapy , Hepatitis B, Chronic*/virology , Hepatitis B, Chronic*/microbiology , Antiviral Agents*/therapeutic use , Antiviral Agents*/administration & dosage , Bacteria*/classification , Bacteria*/drug effects , Bacteria*/genetics , Bacteria*/isolation & purification , Feces*/microbiology , Feces*/virology, Humans ; Male ; Female ; Adult ; Middle Aged ; RNA, Ribosomal, 16S/genetics ; Hepatitis B virus/genetics ; Hepatitis B virus/drug effects
-
10دورية أكاديمية
المؤلفون: Korkmaz Sezer S; Faculty of Medicine, Department of Medical Genetics, Inonu University, Malatya, Turkey., Yuksel S; Faculty of Medicine, Department of Medical Genetics, Inonu University, Malatya, Turkey., Koc A; Faculty of Medicine, Department of Medical Genetics, Inonu University, Malatya, Turkey.; Inonu University, Drug Research and Application Center, Malatya, Turkey., Ulu A; Faculty of Arts and Science, Department of Chemistry, Malatya, Turkey., Ates B; Faculty of Arts and Science, Department of Chemistry, Malatya, Turkey.
المصدر: Drug and chemical toxicology [Drug Chem Toxicol] 2024 Sep; Vol. 47 (5), pp. 516-526. Date of Electronic Publication: 2024 May 10.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Taylor & Francis Group Country of Publication: United States NLM ID: 7801723 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6014 (Electronic) Linking ISSN: 01480545 NLM ISO Abbreviation: Drug Chem Toxicol Subsets: MEDLINE
مواضيع طبية MeSH: Chitosan*/chemistry , Nanoparticles*/toxicity , Reactive Oxygen Species*/metabolism , Tenofovir*/toxicity , Tenofovir*/administration & dosage , Membrane Potential, Mitochondrial*/drug effects , DNA Damage*/drug effects , Micronucleus Tests*, Humans ; Hep G2 Cells ; Comet Assay ; DNA, Mitochondrial/drug effects ; Drug Carriers/chemistry ; Delayed-Action Preparations ; Reverse Transcriptase Inhibitors/toxicity